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Tuesday, March 3, 2009 529aintermembrane space of mitochondria. MAC is a potential therapeutic target, as
modulation of its opening could induce or prevent cell death. Compounds pre-
viously found to block Bax-induced release of fluorescein from liposomes were
tested for their ability to directly inhibit the channel activity of MAC. Patch
clamp techniques were applied to proteoliposomes containing mitochondrial
outer membranes of apoptotic FL5.12 cells to monitor MAC activity. Several
antagonists irreversibly blocked MAC with the IC50’s ranging from 25 to
900 nM. These Inhibitors of MAC, or iMACs, were also effective in preventing
cytochrome c release and progression of apoptosis induced by IL3 deprivation
or staurosporine treatment. A matrix-targeted GFP facilitated visualization of
the collapse of the mitochondrial network during staurosporine-induced apo-
ptosis; this collapse was also prevented by iMACs. The action of these inhib-
itors demonstrates the tight links between MAC activity, cytochrome c
release and apoptosis. Future studies will evaluate the impact of MAC on
mitochondrial dynamics.2721-Pos Board B691
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Transient cerebral ischemia is known to induce endogenous adaptive mecha-
nisms such as the activation of mitochondrial ATP regulated potassium chan-
nels or Ca2þ regulated large conductance potassium channels that can prevent
or delay neuronal injury. In this study a single channel activity was measured
after patch-clamp of the mitoplasts isolated from gerbil hippocampus. In 70%
of the all patches, a potassium selective current was recorded with mean con-
ductance 1095 6 pS in symmetrical 150 mM KCl solution. The patch-clamp
single channel studies showed properties of the voltage-gated potassium chan-
nel (Kv channel). We found that ATP/Mg2þ complex and Ca2þ ions had no
effects on observed activity of ion channel. Observed channel was blocked
by negative voltage and margatoxin (MgTx) a specific Kv1.3 channel inhibitor.
The inhibition byMgTx was irreversible. We conclude that gerbil hippocampus
mitochondria contain voltage-gated potassium channel (mitoKv) with proper-
ties similar to the surface membrane Kv1.3 channel which can play a role
in control function of mitochondria as well as in ischemia-reperfusion phenom-
enon.
This study was supported by grant No. P-N/031/2006 and Polish Mitochondrial
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Large-conductance calcium-activated potassium (BK) channels are expressed
in the plasma membrane of various cell types. Interestingly, recent studies pro-
vide evidence for existence of this channel also in mitochondria. The goal of the
present study was to find a candidate for the regulatory component of the large
conductance calcium activated potassium channel in neurons. A combined
approach of western blot analysis, high-resolution immunofluorescence and
immunoelectron microscopy with the use of antibodies directed against four
distinct beta subunits demonstrated the presence of the BK channel beta4 sub-
unit in the inner membrane of neuronal mitochondria in rat brain and cultured
neurons. Additionally, channel activity was measured with the use of patch-
clamp technique.
The study was supported by grant from Ministry of Science and Higher Educa-
tion No P-N/031/2006 and Polish Mitochondrial Network MitoNet.pl.2723-Pos Board B693
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Bcl-2 can be converted into a pro-apoptotic molecule by nuclear receptor
Nur77. The development of Bcl-2 converters as anti-cancer therapeutics
has been explored by us. We reported recently the identification of
a Nur77-derived Bcl-2 converting peptide (NuBCP) and its enantiomer,
which induce apoptosis of cancer cells in vitro and in animals. The apoptotic
effect of NuBCP enantiomers and their activation of Bax are not inhibited
but rather potentiated by Bcl-2. Using fluorescence polarization assays, we
determined that NuBCP enantiomers bind both quantitatively and stoichio-
metrically to the Bcl-2 loop, which shares the characteristics of structurally
adaptable regions with many cancer-associated signaling proteins. NuBCP-9
enantiomers act as molecular switches to dislodge the Bcl-2 BH4 motif ex-
posing its BH3 motif. Mechanistically we demonstrated, using fluorescence
quenching based liposome assays, that NuBCP-9-induced Bcl-2 conforma-
tional change not only neutralizes Bcl-2’s inhibition of Bax-mediated mem-
brane permeabilization but also exposes the Bcl-2’s BH3 motif that in turn
neutralizes Bcl-XL’s inhibition of Bax like BH3 motif-derived peptides and
compounds. Our results provide mechanistic insight into Bcl-2 conversion
and identify a new direction for developing Bcl-2-based cancer therapeutics.
(This work is in part supported by the grant GM062964 to J. Lin from the
National Institute of Health.)2724-Pos Board B694
Respiratory Complex I Dysfunction Due to Mitochondrial DNAMutations
Shifts the Voltage Threshold for Opening of the Permeability Transition
Pore toward Resting Levels
Anna Maria Porcelli1, Alessia Angelin2, Anna Ghelli1, Elisa Mariani1,
Andrea Martinuzzi3, Valerio Carelli1, Valeria Petronilli4, Michela Rugolo1,
Paolo Bernardi2.
1University of Bologna, Bologna, Italy, 2University of Padova, Padova, Italy,
3IRCSS Medea, Conegliano, Italy, 4CNR Institute of Neuroscience, Padova,
Italy.
We have studied mitochondrial bioenergetics in HL180 cells (a cybrid line har-
boring the T14484C/ND6 and G14279A/ND6 mtDNA mutations of Leber he-
reditary optic neuropathy, leading to an about 50% decrease of ATP synthesis)
and XTC.UC1 cells (derived from a thyroid oncocytoma bearing a disruptive
frameshift mutation in the MT-ND1 gene, which impairs complex I assembly).
Addition of rotenone to HL180 cells and of antimycin A to XTC.UC1 cells
caused fast mitochondrial membrane depolarization that was prevented by
treatment with cyclosporin A, intracellular Ca2þ chelators, and antioxidant.
Both cell lines also displayed an anomalous response to oligomycin, with rapid
onset of depolarization that was prevented by cyclosporin A and by overex-
pression of Bcl-2. These findings indicate that depolarization by respiratory
chain inhibitors and oligomycin was due to opening of the mitochondrial per-
meability transition pore (PTP). A shift of the threshold voltage for PTP open-
ing close to the resting potential may therefore be the underlying cause facil-
itating cell death in diseases affecting complex I activity. This study
provides a unifying reading frame for previous observations on mitochondrial
dysfunction, bioenergetic defects and Ca2þ deregulation in mitochondrial dis-
eases. Therapeutic strategies aimed at normalizing the PTP voltage threshold
may be instrumental in ameliorating the course of complex I-dependent mito-
chondrial diseases.2725-Pos Board B695
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Background: Bax is a pivotal pro-apoptotic Bcl-2 family protein that localizes
to the mitochondrial outer membrane (MOM) during apoptosis and causes
MOM permeabilization to proteins (MOMP). Earlier studies have demon-
strated that upon an apoptotic stimulus, ceramide levels often greatly increase
in cell membranes, including in the MOM. Elevation of ceramide in the MOM
is sufficient to cause MOMP without requiring Bcl-2 family proteins. Moreover
ceramide induced MOMP is reversed/prevented by the anti-apoptotic protein,
Bcl-xL.Methods: Using rat liver or yeast mitochondria, the MOMP was mea-
sured with a dynamic cytochrome c accessibility assay. Ceramide’s channel-
forming ability was also assessed using a defined system: planar phospholipid
membranes. Only C16-ceramide was used. Results:We found that Bax induces
MOMP by apparently enlarging ceramide channels. While ceramide forms
530a Tuesday, March 3, 2009channels independently of Bax, the permeabilization is enhanced by the addi-
tion of less than 5nM oligomeric Bax. As much as 50nM oligomeric Bax alone
did not result in any significant MOMP. The Bax enhancement occurs with an
apparent affinity that increases with an increase in ceramide-induced MOMP,
indicating an underlying mechanism by which Bax enhances ceramide-induced
MOMP. Bax also causes apparent ceramide channel enlargement in yeast
mitochondria, which lack Bcl-2 family proteins, as well as in planar phospho-
lipid membranes, which is a defined, protein free, system. By contrast, mono-
meric Bax has no effect on ceramide channels in the aforementioned systems.
The Bax inhibitor, Bci2 [Bruno Antonsson], prevents Bax mediated channel en-
largement but does not affect permeabilization induced by ceramide alone.
Conclusions: Both pro- and anti-apoptotic proteins regulate ceramide chan-
nels, consistent with ceramide channels being the pathway by which proteins
are released by mitochondria early in apoptosis. (Supported by NSF grant:
MCB-0641208)2726-Pos Board B696
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Mitochondrial outer membrane (MOM) permeabilization and cytochrome c
release from mitochondria into the cytosol are considered to be the commit-
ment steps of the intrinsic apoptotic pathway. Cytochrome c release is regu-
lated by the Bcl-2 family proteins, which contains both pro-apoptotic (e.g.
BAX) and anti-apoptotic (e.g. Bcl-2) members. It is now well established
that after a death signal, cytosolic BAX is translocated to the mitochondrial
outer membrane, inserted then in the double leaflet and activated through
a conformational change. Activated BAX oligomerizes and might be associ-
ated to other mitochondrial proteins, leading to the formation of the Mito-
chondrial Apoptosis-induced Channel (MAC) into the MOM. This channel
allows the release of cytochrome c into the cytosol. Bcl-2 inhibits MAC for-
mation and therefore, cytochrome c release. However, the molecular mecha-
nisms through which Bcl-2 affects earlier steps of BAX-mediated apoptosis
are not fully understood.
In this study we investigated the effects of Bcl-2 over-expression on BAX-
mediated apoptosis. We were able to confirm that Bcl-2 over-expression
inhibits BAX translocation to the MOM and activation/oligomerization, as
previously reported. Bax translocation is generally considered as the primary
target of Bcl-2. Surprisingly, Bcl-2 over-expression did not alter the insertion
status of BAX into the MOM. These data point out the further step, BAX
activation/oligomerization, as the primary target of Bcl-2. Since Bcl-2 does
not inhibit BAX insertion, we hypothesize that an event occurring after cyto-
chrome c release triggers somehow a positive feedback on Bax expression
and translocation. Thus, the inhibition of cytochrome c release by Bcl-2 could
explain the further blocking on BAX translocation.
Supported by NYU Research Challenge Funds to LD.2727-Pos Board B697
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Although several studies have shown that the administration of 17ß-estradiol
(E2) has a cardioprotective effect during ischemia-reperfusion (I/R), the
mechanisms of this action are largely unknown. In this study, we investigated
the effects of E2 on the opening of mPTP and as well on the myocardial in-
farct size after global myocardial I/R injury. Hearts of male mice were iso-
lated and retrograde-perfused through aorta with the Langerdoff system at
37 oC. After 20 min of perfusion, hearts were subjected to 20min global is-
chemia followed by 40min reperfusion. Mitochondria were isolated to mea-
sure Calcium Resistance Capacity (CRC) and mPTP installation; infarct
size was evaluated by triphenyltetrazolium chloride staining (TTC). Experi-
ments were performed in hearts perfused with Krebs Henseleit solution or
with Krebs Henseleit þ E2 (100 pg/ml, corresponding to E2 peak concentra-
tion at proestrus). The E2-treated group had increased CRC (0.73þ0.11 mM
vs. 1.2þ 0.06, p < 0.01) and a reduced infarct size (43 5 3% vs. 68 5
5%, p < 0.01) compared to the control group. The E2-induced infarct size re-
duction was abolished by the specific estrogen receptor antagonist ICI
182,780 (100 nM). These results indicate that a brief E2 exposure favors
CRC by inhibiting the mPTP installation resulting in a reduction of the infarctsize. We propose these actions as a mechanism for E2-induced protection dur-
ing I/R in isolated hearts.
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Emerging evidence suggests that reactive oxygen species (ROS) constitute
a class of signaling molecules that regulate diverse cell functions including
metabolism, muscle contractility and apoptosis. Recently we have developed
and characterized a highly sensitive and reversible superoxide-selective
probe, a circularly permuted yellow fluorescent protein (cpYFP), and demon-
strated quantal and transient superoxide-producing events (superoxide
flashes) within single mitochondria across multiple cell types (Wang et al,
Cell, 132, 279).To further understand the physiological significance of flash
events, we generated the pan-tissue mt-cpYFP transgenic mice expressing
cpYFP in the mitochondria of multiple tissues. In vivo imaging of superoxide
signals in gastrocnemius of
transgenic mouse under anesthe-
sia revealed mitochondrial super-
oxide flashes with similar proper-
ties (Fig). Further, superoxide
flashes were also visualized in iso-
lated skeletal muscle fibers trans-
fected in vivo by electroporation
with mt-cpYFP. Our findings sup-
port that mitochondrial superox-
ide flash activity is a physiologi-
cally relevant phenomenon that
may participate in diverse aspects
of cell function and signaling.2729-Pos Board B699
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Photosensitizer HPPH cooperated with metal complex containing In (III)
(HPPH-In) produces much efficient singlet oxygen production and photody-
namic effects (PDE) as compared to HPPH alone. With the application of
mitochondrial fluorescent probes and laser scanning imaging microscopy,
mitochondrial level of PDE induced by HPPH-In coupled with visible laser
637 nm were investigated in detail. PDE of HPPH-In significantly enhances
depletion of a mitochondria specific fluorescent probe MitoTracker Green at
very earlier time points suggesting its primary targeting on the mitochondrial
membrane. Mitochondria soon swelled and followed by plasma membrane
blebing and later apoptotic condensation of nuclei and cell death. These mito-
chondria-associated apoptotic events induced by PDE of HPPH-In can be par-
tially inhibited by a mitochondria antioxidant, MitoQ, and by the removal of
extracellular Ca2þ suggesting a mROS- and Ca2þ-dependent mechanism is
involved. When mitochondrial reactive oxygen species (ROS) formation and
mitochondrial membrane potential depolarization (DJ) were imaged simulta-
neously, PDE of HPPH-In significantly enhanced mROS formation andDJ de-
polarization with small delay. PDE of HPPH-In-induced increase in mROS
soon propagated to adjacent non-irradiated mitochondrial population as well
as that in adjacent cells and caused depolarization ofDJ of these non-irradiated
mitochondria. In addition to PDE of HPPH-In-enhanced mROS formation, we
observed PDE of HPPH-In-induced sudden depolarization ofDJeffectively re-
duced mROS formation suggesting a possible protective preconditioning may
exist. Finally, PDE of HPPH-In significantly altered mitochondrial dynamics
by decreasing mitochondrial movement and enhancing fission of mitochondria.
These observations suggest that multiple mitochondria-targeted devastating
mechanisms provided by the PDE of HPPH-In coupled with 637 nm laser
